Amoxynil LA Injectable Suspension

COMPOSITION

Amoxynil LA Injectable Suspension is a white – cream coloured, sterile, oily suspension. Each ml contains amoxicillin trihydrate equivalent to 150 mg of amoxicillin.

INDICATIONS FOR USE

Amoxynil LA Injectable Suspension is used in cattle, sheep, dogs and cats in the treatment of gastrointestinal system infections caused by susceptible bacteria (bacterial enteritis, salmonellosis) and urogenital system infections (cystitis, nephritis, pyelonephritis) and respiratory system infections (bronchitis, pneumonia, bronchopneumonia, Pasteurella pneumoniae, enzootic pneumonia, laryngitis, tonsillitis, and secondary bacterial infections accompanying viral pneumonia), especially caused by Pasteurella multocida and M. haemolytica, skin and soft tissue infections such as abscesses, wounds, foot and nail infections, joint and umbilical diseases, prevention and the treatment of post-operative infections and to support local treatment of mastitis and metritis.

ADMINISTRATION ROUTES AND AMOUNTS

Unless advised otherwise by the veterinarian, Amoxynil LA is administered intramuscularly (IM) to cattle and sheep, intramuscularly (IM) and subcutaneously (SC) to dogs and cats. The pharmacological dose of amoxicillin in cattle, sheep, dogs and cats is 15 mg/kg bw.

Practical dose: 1 ml Amoxynil LA / 20 kg bw in cattle, sheep, dogs and cats

Practical dosage table:

Animal species Amoxynil LA Injectable Suspension
الماشية 10 ml / 100 kg bw
Calf 5 ml / 50 kg bw
الخراف 2.5 ml / 25 kg bw
Lamb 1 ml / 10 kg bw
Dog 1 ml / 10 kg bw
Cat 0.5 ml / 5 kg bw

Shake the vial vigorously before use to obtain a homogenous suspension. Apply massage to the site after subcutaneous and intramuscular injections. If the dose is more than 20 ml for cattle and 5 ml for sheep, it is recommended to be divided and injected into two different sites. Penicillin preparations generally hydrolyze quickly in the watery environment. For this reason, dry needle and syringe should be used for injection. Asepsis and antisepsis should be taken into account during administration.

WITHDRAWAL PERIOD(S)

Cattle and sheep should not be slaughtered for human consumption during the treatment and for 30 days following the last treatment. Cow milk should not be used for human consumption during the treatment and for 5 days (10 milkings) following the last treatment. Sheep milk should not be used for human consumption during the treatment and for 7 days (14 milkings) following the last treatment. Withdrawal period for the injection site is 50 days in cattle and sheep. As the withdrawal period for milk is long, it is not recommended to use in sheep producing milk for human consumption.

MARKETING PACKAGING

50 ml, 100 ml and 250 ml in colourless glass vials inside cardboard boxes.